Development of a European Organization for research and treatment of Cancer Module to Assess the Quality of Life of Patients with Proctitis after Pelvic Radiotherapy for Malignancy
MetadataShow full item record
To describe the development of a proctitis-specific quality-of-life module to supplement the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30). The module was developed according to EORTC guidelines, which consisted of an extensive literature review to identify previously described issues and interviews conducted with seven health professionals and 10 patients to rationalize the item list for construction into a provisional module. The module developed was then pretested with 28 patients and five health professionals. The final module contains 21-items that are suitable to obtain information about the patients' quality of life after high-dose pelvic irradiation. The questionnaire has now been translated into four languages and commenced field testing in late 2007. The EORTC QLQ-C30, supplemented by EORTC QLQ-PRT21, will enable health professionals to more accurately monitor the side effects that patients experience after pelvic irradiation.
Spry, Nigel and Halkett, Georgia and Spry, Jane. 2008. Development of a European Organization for research and treatment of Cancer Module to Assess the Quality of Life of Patients with Proctitis after Pelvic Radiotherapy for Malignancy. International Journal of Radiation Oncology Biology Physics 72 (2): pp. 522-528.
Copyright © 2008 Elsevier B.V. All rights reserved
Showing items related by title, author, creator and subject.
International validation of the EORTC QLQ-PRT20 module for assessment of quality of life symptoms relating to radiation proctitis: a phase IV study.Halkett, Georgia; Wigley, C.; Aoun, Samar; Portaluri, M.; Tramacere, F.; Livi, L.; Detti, B.; Arcangeli, S.; Lund, J.; Kristensen, A.; McFadden, N.; Grun, A.; Bydder, S.; Sackerer, I.; Greimel, E.; Spry, N.; EORTC Quality of Life Group (2018)BACKGROUND: Although patients experience radiation proctitis post radiotherapy no internationally tested instruments exist to measure these symptoms. This Phase IV study tested the scale structure, reliability and validity ...
Adverse effects to quality of life arising from treatment can recover with intermittent androgen suppression in men with prostate cancer.Spry, N.; Kristjanson, Linda; Hooton, B.; Hayden, L.; Neerhut, G.; Gurney, H.; Corica, T.; Korbel, E.; Weinstein, S.; McCaul, Kieran (2006)Health-related quality of life (HQOL) research is a means of broadening the assessment of treatment effects. This longitudinal study investigated the dynamic change to quality of life (QOL) and testosterone dependant ...
What pelvic radiation disease symptoms are experienced by patients receiving external beam radiotherapy and a high-dose-rate brachytherapy boost for prostate cancer?Halkett, Georgia; Short, M.; Aoun, Samar; Joseph, D.; Bydder, S.; Meng, X.; Spry, N. (2017)Purpose: Research describing proctitis or pelvic radiation disease symptoms of prostate cancer patients one year after external beam radiotherapy (EBRT) plus high-dose-rate (HDR) brachytherapy is limited. This study aimed ...